SG Americas Securities
PASG icon

SG Americas Securities’s Passage Bio PASG Stock Holding History

SG Americas Securities’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-538
Closed -$33K – 3554
2022
Q1 		$33K Sell
538
-265
-33% -$21.8K ﹤0.01% 2867
2021
Q4 		$102K Sell
803
-1,038
-56% -$170K ﹤0.01% 3077
2021
Q3 		$367K Buy
1,841
+1,451
+372% +$346K ﹤0.01% 2768
2021
Q2 		$103K Buy
390
+15
+4% +$4.64K ﹤0.01% 2662
2021
Q1 		$131K Buy
+375
New +$160K ﹤0.01% 2936
2020
Q3 		– Sell
-223
Closed -$122K – 3257
2020
Q2 		$122K Buy
+223
New +$100K ﹤0.01% 3236

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's PASG Position: Q2 2022 in Review

SG Americas Securities sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 538 shares — an estimated $33K sold.

SG Americas Securities first reported a position in PASG in Q2 2020 and held it in 6 quarters. The position peaked at $367K in Q3 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • SG Americas Securities reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • SG Americas Securities sold 538 Passage Bio shares in Q2 2022, an estimated $33K.
  • SG Americas Securities first reported a position in Passage Bio in Q2 2020 and held it in 6 quarters.
  • SG Americas Securities's Passage Bio position peaked at $367K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.